{"id":"W1990194653","doi":"10.1016/j.gtc.2010.08.018","title":"Tumor Necrosis Factor-α Monoclonal Antibodies in the Treatment of Inflammatory Bowel Disease: Clinical Practice Pharmacology","year":2010,"lang":"en","type":"review","venue":"Gastroenterology Clinics of North America","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Certolizumab pegol; Infliximab; Adalimumab; Inflammatory bowel disease; Ulcerative colitis; Vedolizumab; Monoclonal antibody; Tumor necrosis factor alpha; Crohn's disease; Immunology; Disease; Psoriasis; Antibody; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008046742,0.00102745,0.001785244,0.00161302,0.0002162709,0.0008521179,0.0009837431,0.001190451,0.002444021],"category_scores_gemma":[0.0008320526,0.0002987079,0.0004814108,0.001643106,0.0004699008,0.001057129,0.0005588868,0.002587274,0.001876509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005624531,"about_ca_system_score_gemma":0.0008677809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001006967,"about_ca_topic_score_gemma":0.002544741,"domain_scores_codex":[0.9998087,0.00003449517,0.00002675148,0.00002788652,0.0000837054,0.00001851387],"domain_scores_gemma":[0.9995999,0.0001786246,0.00006462394,0.00001127304,0.0001030918,0.00004256316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002010576,0.0001494997,0.0001415037,0.006939261,0.0001012311,0.0002059192,0.00002215667,0.0003683518,0.001761149,0.001582725,0.03660087,0.9519264],"study_design_scores_gemma":[0.0002143091,0.0002838837,0.001018896,0.00248457,0.0002364949,0.002030996,0.00003876751,0.0002272192,0.0008579321,0.001517316,0.9910629,0.00002686951],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001098517,0.9985034,0.0001766526,0.0002808146,0.0002629479,0.000005884681,0.00001100621,0.000007838279,0.0006416086],"genre_scores_gemma":[0.0007235424,0.9976134,0.0003182608,0.0003212032,0.0003158801,0.0000088712,0.00002530997,0.000001726874,0.0006717636],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002444021,"threshold_uncertainty_score":0.008176088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02603943426879796,"score_gpt":0.3666919273421982,"score_spread":0.3406524930734003,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}